EMA 的 EudraGMDP 数据库现代化升级,新版计划于 2027 年第一季度上线
EudraGMDP database
EMA 正在对 EudraGMDP 数据库进行现代化改造,新版计划于 2027 年第一季度上线,将提升系统稳定性、可用性和搜索功能,并增强 EMA 各系统间的数据质量与一致性。该数据库由 EMA 维护运营,EEA 监管机构拥有完整读写权限,互认协议国家也已获得写入权限以替代纸质证书交换。
This content applies to human and veterinary medicines.
EudraGMDP is undergoing modernisation, with the new EudraGMDP scheduled to launch in Q1 2027. The modernisation improves system stability, usability, and search functionalities. It also enhances data quality and consistency across EMA systems.
The database aims to:
- improve the sharing of information between regulators and the public, including the pharmaceutical industry;
- aid the coordination of inspections of manufacturers in third countries among national competent authorities;
- eliminate the need for industry to submit paper documents to support marketing-authorisation and variation applications;
- help protect the medicine distribution chain and active-substance supply chain by facilitating the verification of legitimate actors;
- facilitate the sharing of information on the outcomes of inspections conducted by European Economic Area (EEA) authorities with regulatory authorities elsewhere in the world.
EEA Member States include data in the EudraGMDP database as it becomes available. Regulatory authorities in the EEA have full read and write access to EudraGMDP. EudraGMDP is maintained and operated by EMA.
Countries with mutual recognition agreements have also been offered write access, to replace the exchange of paper certificates needed for these agreements to operate.
For more information, see:
History of EudraGMDP database
April 2007
Launch of EudraGMDP
July 2009
Addition of GMP non-compliance of manufacturers
December 2012
Addition of planning module
The planning module for national competent authorities (medicines regulators in European Union Member States) is for sharing inspection plans for manufacturers in third countries (countries outside the EU). This planning module is not visible in the public version of the database.
April 2013
Extension of coverage
Extending coverage to GDP-related information and registration of manufacturers, importers and distributors of active substances.
来源:EMA Inspections · ema.europa.eu